Skip to main content
. 2003 Oct 20;2003(4):CD001332. doi: 10.1002/14651858.CD001332

Pellkofer 1989.

Methods Parallel‐group study lasting up to 35 days
Participants 47 MS patients with disabling lower limb spasticity
Interventions Tetrazepam v. tizanidine v. baclofen (doses optimised but not reported)
Outcomes EDSS, Ashworth scale, symptom reports, unvalidated 4‐point scale of tolerability and 5‐point scale of overall therapeutic effect
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear